Skip to content
JOIN 7INVESTING TODAY – YOUR PORTFOLIO WILL THANK YOU!
LOGIN
Toggle Navigation
My Account
Advisor Updates
View All
Best Buys
Community Ideas
Strong Buys
Subscriber Calls
Watchlist
Company Updates
View All
Deep Dives
Recommendations
Articles
Portfolios
MENU
My Account
Advisor Updates
View All
Best Buys
Community Ideas
Strong Buys
Subscriber Calls
Watchlist
Company Updates
View All
Deep Dives
Recommendations
Articles
Portfolios
LOGIN
SUBSCRIBE TODAY
Search for:
FILTER CONTENT
Filters
Filters
×
Risk Levels
Low Risk
(
2
)
Moderate Risk
(
3
)
High Risk
(
2
)
Very High Risk
(
15
)
Investment Styles
Income
(
2
)
Growth
(
18
)
Value
(
2
)
Industries
Retail
(
11
)
Enterprise Software
(
16
)
Consumer Discretionary
(
20
)
Consumer Staples
(
4
)
Internet Infrastructure
(
8
)
Semiconductors
(
7
)
Industrial
(
3
)
Pharmaceuticals
(
10
)
Biotechnology
(
28
)
Media
(
2
)
Telecommunications
(
1
)
Energy
(
6
)
Financial Services
(
31
)
Banking
(
1
)
Commodities
(
1
)
Consumer Electronics
(
5
)
Entertainment
(
10
)
Health Care Technology
(
11
)
Insurance
(
3
)
Transportation
(
2
)
Travel
(
2
)
Space Economy
(
4
)
Cannabis
(
2
)
Real Estate
(
2
)
General
(
25
)
Advertising
(
1
)
Show
(
41
)
Cancel
Research
By
Maxx Chatsko
Published On: May 1, 2022
May 2022 Stock Rec #5
READ MORE
By
Maxx Chatsko
Published On: April 15, 2022
April 2022 Best Buy #2
READ MORE
By
Maxx Chatsko
Published On: April 1, 2022
April 2022 Stock Rec #6
READ MORE
By
Maxx Chatsko
Published On: March 1, 2022
March 2022 Stock Rec #2
READ MORE
By
Maxx Chatsko
Published On: February 8, 2022
Will Solid-State Batteries Live Up to the Hype?
READ MORE
By
Maxx Chatsko
Published On: February 1, 2022
February 2022 Stock Rec #5
READ MORE
By
Maxx Chatsko
Published On: January 26, 2022
“Very High Risk” Isn’t Very Helpful
READ MORE
By
Maxx Chatsko
Published On: January 14, 2022
Should You Invest in Synthetic Biology Stocks?
READ MORE
By
Maxx Chatsko
Published On: January 1, 2022
January 2022 Stock Rec #2
READ MORE
By
Samantha Bailey
Published On: December 20, 2021
Can Better Antibodies Disrupt Cell Therapy?
READ MORE
By
Maxx Chatsko
Published On: December 1, 2021
December 2021 Stock Rec #5
READ MORE
By
Maxx Chatsko
Published On: November 13, 2021
I Choose Embarrassment
READ MORE
By
Maxx Chatsko
Published On: November 1, 2021
November 2021 Stock Rec #2
READ MORE
By
Maxx Chatsko
Published On: October 14, 2021
Drug Development is Risky. Let’s Count the Ways.
READ MORE
By
Maxx Chatsko
Published On: October 1, 2021
October 2021 Stock Rec #3
READ MORE
By
Maxx Chatsko
Published On: September 14, 2021
Annual 2021 Review: Maxx’s 7investing Recommendations
READ MORE
1
2
Next
Load More Picks
Page load link
Go to Top
